Metraipolis › archive › dc_911b5ab0cdc8

Perceived ease of use of Truenat among laboratory staff as a new diagnostic tool for TB in Nigeria: Result of a pilot roll-out — Europe PMC PMID:39302944

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39302944
DOI
10.1371/journal.pgph.0003652
License (as archived)
CC0-1.0
Archived
2026-10-06T15:19:54.534Z
SHA-256 of the archived text
96ab029b785c9a1e9d094558738ffd63aec00e9469568d6044af0318af5b1ae4
Stable URL of this page
https://metraipolis.com/documento/dc_911b5ab0cdc8

How to cite

Perceived ease of use of Truenat among laboratory staff as a new diagnostic tool for TB in Nigeria: Result of a pilot roll-out — Europe PMC PMID:39302944 — Europe PMC (en), https://europepmc.org/article/MED/39302944 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_911b5ab0cdc8 (Metraipolis archive dc_911b5ab0cdc8, sha256 96ab029b785c9a1e9d094558738ffd63aec00e9469568d6044af0318af5b1ae4)
BibTeX
@misc{dc911b5ab0cdc8,
  title = {Perceived ease of use of Truenat among laboratory staff as a new diagnostic tool for TB in Nigeria: Result of a pilot roll-out — Europe PMC PMID:39302944},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39302944},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_911b5ab0cdc8; sha256 96ab029b785c9a1e9d094558738ffd63aec00e9469568d6044af0318af5b1ae4},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/39302944. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

In January 2020, WHO released a rapid communication on use of molecular assays as initial tests for diagnosis of tuberculosis, recommending Truenat as a replacement for smear microscopy in TB diagnosis. This study was designed to assess perceived ease of use of Truenat among Laboratory staff as a new diagnostic tool for TB in Nigeria. This study used a cross-sectional design. All trained Laboratory personnel operating the Truenat Duo equipment in 38 Truenat sites in the country were included. Information was obtained using a pre-tested self-administered questionnaire. Ease of use of Truenat was assessed using twenty-three variables on a five-point Likert scale of 1-5. The variables were analyzed quantitatively and qualitatively. Good Ease of use of Truenat was determined by proportion of respondents who answered ≥70% of the variables in the positive. All 50 Truenat Laboratory staff participated in the study. (Response rate 100%). Majority, (58%) were male. The median estimated number of tests before Laboratory staff became proficient with Truenat machine was 9 (IQR, 4-20), median number of tests to be analyzed within eight working hours was 10, (IQR = 8-15) and median time to conduct a Truelab MTBPlus test from start to finish was 60 minutes (IQR = 60-80). The commonest operational challenge that required Molbio service support was Trueprep errors/blockage, 47.4%. Overall, mean ease of use score was 4.0±0.4. Majority, (76%) had Good Ease of use of Truenat. No factor significantly influenced Ease of use of Truenat. Truenat machine is easy to use for a trained laboratory staff with minimal technical support and hence could be rolled out easily and successfully by various National TB Programs. Considering the high Trueprep challenges reported, there is need for further studies into the common errors/challenges, the contexts surrounding them and the programmatic intervention to address the high rate of Trueprep equipment faults.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLOS global public health, 2024 (prima pubblicazione 2024-09-20).
Identificativi: PMID 39302944 · PMCID PMC11414918 · DOI 10.1371/journal.pgph.0003652.
Pagina: https://europepmc.org/article/MED/39302944 — https://doi.org/10.1371/journal.pgph.0003652. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T15:11:56.427Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.